Among the myriad drugmakers laying out their plans for the future at this year’s J.P. Morgan Healthcare Conference, Takeda said it's laser-focused on six pipeline assets that could each reel in ...

Three years after it was formed as a spinout of Japanese drugmaker Takeda, Phathom Pharmaceuticals ... around 115 million people in the US, and standard therapy is eradication with a combination ...

It's never finished but I think we have made great steps forward. Related stories Insider: You mention the Shire acquisition. How important has that been for Takeda's global transformation journey?

Bone-chilling temperatures couldn’t keep the crowds away from Takeda’s Kendall Square campus on Tuesday to celebrate a milestone for the Japanese drugmaker’s new R&D tower. More than 250 ...